Treatment of Peripheral Neuropathy in Patients With Diabetes

Completed · Phase 3

Conditions studied: Diabetic Neuropathies, Diabetes Mellitus

In brief

The purpose of this protocol is to determine if an investigational drug is effective in treating nerve malfunction in diabetes.

Key facts

Study ID
NCT00044421
Run by
Eli Lilly and Company
People needed
400
Starts
2002-07-01
Expected to finish
2006-10-01
Last updated by the study team
2007-11-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.